135 related articles for article (PubMed ID: 1907723)
1. Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig.
Fornstedt B; Carlsson A
Neuropharmacology; 1991 May; 30(5):463-8. PubMed ID: 1907723
[TBL] [Abstract][Full Text] [Related]
2. A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment.
Fornstedt B; Carlsson A
J Neural Transm; 1989; 76(2):155-61. PubMed ID: 2496196
[TBL] [Abstract][Full Text] [Related]
3. In vivo autoxidation of dopamine in guinea pig striatum increases with age.
Fornstedt B; Pileblad E; Carlsson A
J Neurochem; 1990 Aug; 55(2):655-9. PubMed ID: 2370552
[TBL] [Abstract][Full Text] [Related]
4. Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson's disease and during ageing in non-Parkinsonian subjects.
Fornstedt Wallin B
J Neural Transm (Vienna); 2024 Mar; 131(3):213-228. PubMed ID: 38238531
[TBL] [Abstract][Full Text] [Related]
5. Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum.
Fornstedt B; Carlsson A
J Neurochem; 1991 Feb; 56(2):407-14. PubMed ID: 1988547
[TBL] [Abstract][Full Text] [Related]
6. Reserpine-insensitive dopamine release in the substantia nigra?
Elverfors A; Nissbrandt H
Brain Res; 1991 Aug; 557(1-2):5-12. PubMed ID: 1720998
[TBL] [Abstract][Full Text] [Related]
7. Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain.
Westerink BH; Korf J
Eur J Pharmacol; 1976 Jun; 37(2):249-55. PubMed ID: 954808
[TBL] [Abstract][Full Text] [Related]
8. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
Nissbrandt H; Carlsson A
J Neurochem; 1987 Sep; 49(3):959-67. PubMed ID: 3612134
[TBL] [Abstract][Full Text] [Related]
9. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
10. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
Waldmeier PC; Maître L
Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
[TBL] [Abstract][Full Text] [Related]
11. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Nissbrandt H; Engberg G; Pileblad E
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
[TBL] [Abstract][Full Text] [Related]
13. The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra.
Fornstedt B; Brun A; Rosengren E; Carlsson A
J Neural Transm Park Dis Dement Sect; 1989; 1(4):279-95. PubMed ID: 2597314
[TBL] [Abstract][Full Text] [Related]
14. Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion.
Kita T; Wagner GC; Philbert MA; King LA; Lowndes HE
Mol Chem Neuropathol; 1995 Jan; 24(1):31-41. PubMed ID: 7755845
[TBL] [Abstract][Full Text] [Related]
15. Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum.
Adachi YU; Yamada S; Satomoto M; Higuchi H; Watanabe K; Kazama T
Brain Res Bull; 2005 Oct; 67(3):176-81. PubMed ID: 16144652
[TBL] [Abstract][Full Text] [Related]
16. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
17. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
Kato T; Dong B; Ishii K; Kinemuchi H
J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
[TBL] [Abstract][Full Text] [Related]
18. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat.
Garrett MC; Soares-da-Silva P
Neuropharmacology; 1990 Oct; 29(10):875-9. PubMed ID: 2123970
[TBL] [Abstract][Full Text] [Related]
19. Dopamine, noradrenaline and 3,4-dihydroxyphenylacetic acid (DOPAC) levels of individual brain nuclei, effects of haloperidol and pargyline.
Fekete MI; Herman JP; Kanyicska B; Palkovits M
J Neural Transm; 1979; 45(3):207-18. PubMed ID: 479873
[TBL] [Abstract][Full Text] [Related]
20. An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid.
Fornstedt B; Bergh I; Rosengren E; Carlsson A
J Neurochem; 1990 Feb; 54(2):578-86. PubMed ID: 2105377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]